With quality as the top priority, GYBYS conducts science-based and traceable quality control to ensure product safety and effectiveness. The Company continues to strengthen its legal compliance operation and quality culture across the board, dedicating to improving the accessibility and affordability of high quality pharmaceutical products. On its global journey, GYBYS is committed to benefiting more people with premium quality services, contributing to sustainability with solid social responsibility practices.

n Our Commitments

Ø Build a quality guardianship system ensuring full-chain controllability.

Ø Solidify a closed-loop quality management system with end-to-end traceability.

Ø Create a benchmark for quality control driven by the pursuit of perfection.

n Our Actions

Ø Strict Product Quality Control：GYBYS always upholds the "quality first" philosophy. We continuously strengthen our awareness of legal and compliant operations, establish a comprehensive quality management system, and actively carry out quality management initiatives. We also foster a company-wide quality culture and build a systematic and effective pharmacovigilance system. These efforts build a solid defense for product quality and safety, providing every customer with safe and effective products. In 2025,no major product quality or safety incidents occurred.

Ø Product Accessibility：GYBYS is dedicated to expanding drug accessibility and enhancing the affordability of medical services to meet residents' growing needs. We are committed to channeling high-quality medical resources to the primary level, ensuring that safe, effective, and reliable products benefit a wider population. Focusing on critical disease areas, we leverage independent innovation and collaborative R&D to develop superior, accessible treatments that alleviate the financial burden on patients. Furthermore, we actively promote TCM science popularization to raise public scientific literacy while preserving and advancing traditional Chinese medicine culture.

Ø Customer Rights and Interests Protection：Adhering to a customer-centric approach, GYBYS fully respects and protects customers' legitimate rights and interests. We enhance service quality by conveying authentic drug information, understanding user needs, and optimizing experiences to boost satisfaction. We have established systematic customer service and complaint handling mechanisms across our subsidiaries, while strictly safeguarding the personal information of customers, patients, and employees. Furthermore, we conduct regular business risk analyses to ensure full compliance with laws and regulations. Any non-compliant practices are subject to immediate rectification, and accountability is enforced for violations or inadequate risk control, thereby upholding our brand reputation.

n Our Performance

Ø Our subsidiaries achieved a 100% pass rate in various types of sampling inspections.

Ø GYBYS and its subsidiaries operate a total of 167 pharmaceutical retail outlets, covering several provinces in South and Southwest China.

Ø our subsidiaries newly released a total of 86 standards, including leading or participating in 23 pharmaceutical-related standards and 63 healthcare standards, contributing to the improvement of industry standards.

Ø At the 46th National Pharmaceutical Industry QC Group Achievements Exchange Conference, 26 subsidiaries won 36 first prizes and 17 Best Presentation Awards.

n Our Stories